Skip to content

CLYDESDALE PTC™ Spinal System 4986040Recalls & reported problems

Medtronic Sofamor Danek, Inc. · CAGE 4986040 CDALE PTC 18MM 6 DEG 10X40 · Class 2 · Implant

All models of CLYDESDALE PTC Spinal System (28)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169190740), received between Nov 8, 2018 and Mar 11, 2025 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Device Dislodged or Dislocated1
  • Mechanical Problem1
  • Use of Device Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Blood Loss1
  • Injury1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 11, 2025Mechanical Problem; Mechanical Problem

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

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21571357 ↗
  • InjurySep 21, 2023Use of Device Problem; Device Dislodged or Dislocated; Use of Device Problem; Device Dislodged or Dislocated

    ADDITIONAL INFORMATION RECEIVED THAT THE DEVICE WILL BE RETURNED TO THE CUSTOMER AND IT WON'T BE RETURNED TO BU.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17787150 ↗
  • InjuryNov 8, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PRE-OPERATIVE DIAGNOSIS FOR THIS PROCEDURE: LUMBAR KYPHOSCOLIOSIS TYPE OF PROCEDURE OR TECHNIQUE USED: OLIF (OBLIQUE LUMBAR INTERBODY FUSION) LEVELS IMPLANTED: L2/3/4 IT WAS REPORTED THAT INTRA-OP, AFTER IMPLANTATION WAS COMPLETED, WHEN PERFORMING HEMOSTASIS TO THE BLEEDING FROM THE END PLATE OF VERTEBRAL BODY, THE SOMATIC ARTERY WAS INJURED CAUSING BLOOD LOSS OF ABOUT 500-600ML. HEMOSTASIS WAS PERFORMED WITH FACILITY OWNED TWEEZER AND GAUZE. THE WOUND WAS CLOSED BY SPRINKLING THE FLOSEAL AFTER HEMOSTASIS WITH ASTRICTION OR CAUTERIZATION. THERE WAS A DELAY OF LESS THAN 60 MINUTES IN OVERALL PROCEDURE TIME AS A RESULT OF THIS EVENT. NO EXTENDED HOSPITALIZATION WAS REQUIRED FOR THE PATIENT DUE TO THE ADVERSE EVENT. NO MALFUNCTION WAS REPORTED FOR THE PRODUCT; AND THE INJURY WAS NOT CAUSED DUE TO THE PRODUCT. POSTERIOR FUSION WAS PLANNED TO BE PERFORMED; HOWEVER NO INFORMATION IS AVAILABLE IF IT WAS ACTUALLY PERFORMED.

    Patient problems: Blood Loss; Injury

    MAUDE report 8050174 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page